1. Home
  2. Investing
  3. Stocks
  4. USA
  6. BioCardia Inc (BCDA)
  7. Quote


BioCardia Stock Price

-0.13 (-6.47%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 55,970
Bid Price 1.26
Ask Price 2.48
News -
Day High 2.08


52 Week Range


Day Low 1.87
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BioCardia Inc BCDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -6.47% 1.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.03 1.87 2.08 1.88 2.01
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
320 55,970 $ 1.94 $ 108,453 - 1.87 - 8.60
Last Trade Time Type Quantity Stock Price Currency
16:00:00 163 $ 1.88 USD


Draw Mode:

BioCardia Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 31.72M 16.87M 14.25M $ 145.00k $ - -1.58 -3.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 36.87k -

more financials information »

BioCardia News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.232.371.872.0658,755-0.35-15.7%
1 Month2.852.901.872.2853,008-0.97-34.04%
3 Months3.053.961.873.27149,619-1.17-38.36%
6 Months4.285.09881.873.53108,785-2.40-56.07%
1 Year2.498.601.875.261,044,855-0.61-24.5%
3 Years5.248.601.875.06484,794-3.36-64.12%
5 Years5.248.601.875.06484,794-3.36-64.12%

BioCardia Description

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.